PetVivo Holdings (PETV) Stock Analysis & Winston Score
PetVivo Holdings is a small medical device company that makes treatments for animals, mainly pets like dogs and cats. Its main product is Spryng, an injectable device that helps relieve joint pain in animals without surgery. The company sells to veterinarians, who then use the product to treat pets suffering from osteoarthritis. PetVivo earns money by selling its Spryng product directly to veterinary clinics across the United States. The company is very small, with a market cap near zero, and is not yet profitable — its operating losses are far larger than its revenue. The core risk is that the company is burning through cash while trying to build awareness and adoption among vets, and it will likely need to raise more money to keep operating.
Winston Score: 31/100 — Below Average
Below-average fundamentals — multiple weak pillars.
- Quality: Mixed (10/30)
- Growth: Mixed (5/20)
- Cash Flow: Weak (0/10)
- Stability: Mixed (4/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: $0.77
Market Cap: $23M
Sector: Healthcare
Industry: Medical - Devices
